Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine

Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the course of hyper and normoprolactinem...

Descripción completa

Detalles Bibliográficos
Autores principales: Camkurt, Mehmet Akif, Gülpamuk, Gizem, Fındiklı, Ebru, Elve, Rengin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426493/
https://www.ncbi.nlm.nih.gov/pubmed/28449567
http://dx.doi.org/10.9758/cpn.2017.15.2.181
_version_ 1783235489212399616
author Camkurt, Mehmet Akif
Gülpamuk, Gizem
Fındiklı, Ebru
Elve, Rengin
author_facet Camkurt, Mehmet Akif
Gülpamuk, Gizem
Fındiklı, Ebru
Elve, Rengin
author_sort Camkurt, Mehmet Akif
collection PubMed
description Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the course of hyper and normoprolactinemic galactorrhea. We managed this side effect initially by dose reduction and further by switching to essitalopram. Physicians should be aware of endocrinologic side effects such as galactorrhea during the serotonin and noradrenaline reuptake inhibitor treatment.
format Online
Article
Text
id pubmed-5426493
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-54264932017-05-12 Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine Camkurt, Mehmet Akif Gülpamuk, Gizem Fındiklı, Ebru Elve, Rengin Clin Psychopharmacol Neurosci Case Report Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the course of hyper and normoprolactinemic galactorrhea. We managed this side effect initially by dose reduction and further by switching to essitalopram. Physicians should be aware of endocrinologic side effects such as galactorrhea during the serotonin and noradrenaline reuptake inhibitor treatment. Korean College of Neuropsychopharmacology 2017-05 2017-05-31 /pmc/articles/PMC5426493/ /pubmed/28449567 http://dx.doi.org/10.9758/cpn.2017.15.2.181 Text en Copyright © 2017, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Camkurt, Mehmet Akif
Gülpamuk, Gizem
Fındiklı, Ebru
Elve, Rengin
Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine
title Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine
title_full Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine
title_fullStr Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine
title_full_unstemmed Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine
title_short Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine
title_sort dose dependent course of hyperprolactinemic and normoprolactinemic galactorrhea induced by venlafaxine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426493/
https://www.ncbi.nlm.nih.gov/pubmed/28449567
http://dx.doi.org/10.9758/cpn.2017.15.2.181
work_keys_str_mv AT camkurtmehmetakif dosedependentcourseofhyperprolactinemicandnormoprolactinemicgalactorrheainducedbyvenlafaxine
AT gulpamukgizem dosedependentcourseofhyperprolactinemicandnormoprolactinemicgalactorrheainducedbyvenlafaxine
AT fındiklıebru dosedependentcourseofhyperprolactinemicandnormoprolactinemicgalactorrheainducedbyvenlafaxine
AT elverengin dosedependentcourseofhyperprolactinemicandnormoprolactinemicgalactorrheainducedbyvenlafaxine

Ejemplares similares